A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Study sponsor: Climb Bio, Inc. · CLYM
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-10Estimated
Enrollment · participants45Estimated
Source updated2026-10-08Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.